Abdullah Alattar

15PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursProteins and peptidesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 31, 2025
Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise.

Fawaz E Alanazi, Yasser Alatawi, Abdullah Alattar

|Nov 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis.

Yasser Alatawi, Fawaz E Alanazi, Abdullah Alattar

|Nov 27, 2025
Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review.

Helal F Hetta, Yasser Alatawi, Fawaz E Alanazi

|Sep 27, 2025
Recent Advances in the Development of Pro-PROTAC for Selective Protein Degradation.

Fady Hakem, Ahmad Abdelwaly, Reem Alshaman

|Jan 08, 2025
Spanlastic Nano-Vesicles: A Novel Approach to Improve the Dissolution, Bioavailability, and Pharmacokinetic Behavior of Famotidine.

Hend I Almohamady, Yasmin Mortagi, Shadeed Gad

Pageof 3